AHK-Cu Dosage Protocols: Research Model Comparison Key Takeaways AHK-Cu protocols studied in research settings range from 0.252mg daily via subcutaneous injection, with mid-range doses (0.751.5mg) most commonly extrapolated from preclinical models
The batches incorporated 2: 1, 3:2 and 1.66: 1 ratio of these permeation enhancers
In addition, chronological aging of the skin is influenced by genetics, metabolism, and hormonal, immunological, cardiovascular, gastrointestinal, psychogenic (involving stress or affective disorders), degenerative, or neoplastic disease [16,17,18]
2d), 1.301 0.220 M (Fig
Depending on your health needs and symptoms, B12 or B complex may be better suited for you